| Cat. No. |
Product Name |
Information |
| PC-62936 |
GNE-220
MAP4K4 inhibitor
|
GNE-220 is a potent and selective inhibitor of MAP4K4 with IC50 of 7 nM, also inhibits MINK (MAP4K6), DMPK and KHS1 (MAP4K5) with IC50 of 9 nM, 476 nM and 1,110 nM. |
| PC-62935 |
MAP4K4-IN-17
MAP4K4 inhibitor
|
MAP4K4-IN-17 is a potent and highly selective MAP4K4 inhibitor with IC50 of 14.9 nM, showes improved overall drug-like properties compared to PF-06260933. |
| PC-61694 |
PF-06260933 dihydrochloride
MAP4K4 inhibitor
|
PF-06260933 dihydrochloride is a potent, selective and orally bioavailable MAP4K4 inhibitor with kinase IC50 of 3.7 nM, cell IC50 of 160 nM. |
| PC-61165 |
MAP4K4-IN-11e
MAP4K4 inhibitor
|
MAP4K4-IN-11e is a potent, selective, ATP-competitive inhibitor of MAP4K4 with IC50 of 1.9 uM, without effect on other stress pathway related kinases. |
| PC-60014 |
PF-06260933
MAP4K4 inhibitor
|
PF-06260933 (PF06260933,PF6260933) is a potent, selective, orally available MAP4K4 inhibitor with IC50 of 3.7 nM. |
| PC-42105 |
GNE-495
MAP4K4 inhibitor
|
GNE-495 (GNE495) is a potent and highly selective, cell permeable MAP4K4 inhibitor with IC50 of 3.7 nM. |
| PC-38665 |
HPK inhibitor compound 1
HPK1 inhibitor
|
HPK inhibitor compound 1 is an allosteric, inactive conformation-selective HPK1 inhibitor, binds to unphosphorylated HPK1 and >24-fold more potently than active HPK1. |
